The store will not work correctly when cookies are disabled.
2-(1H-Indol-2-yl)phenyl benzoate
ID: ALA4569151
PubChem CID: 155550761
Max Phase: Preclinical
Molecular Formula: C21H15NO2
Molecular Weight: 313.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Oc1ccccc1-c1cc2ccccc2[nH]1)c1ccccc1
Standard InChI: InChI=1S/C21H15NO2/c23-21(15-8-2-1-3-9-15)24-20-13-7-5-11-17(20)19-14-16-10-4-6-12-18(16)22-19/h1-14,22H
Standard InChI Key: ZMAWHOKWRLMZSM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
5.4358 -6.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4346 -7.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1494 -7.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1476 -5.8702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8629 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8678 -7.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6597 -7.3625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1443 -6.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6517 -6.0179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9671 -6.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3832 -7.3930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2074 -7.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6164 -6.6711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1953 -5.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3725 -5.9648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9539 -5.2539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3602 -4.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9415 -3.8252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1851 -4.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5978 -5.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4220 -5.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8291 -4.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4059 -3.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5832 -3.8115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
15 16 1 0
16 17 1 0
17 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 313.36 | Molecular Weight (Monoisotopic): 313.1103 | AlogP: 5.05 | #Rotatable Bonds: 3 |
Polar Surface Area: 42.09 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.30 | CX LogD: 5.30 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.42 | Np Likeness Score: -0.46 |
References
1. Sherer C, Prabhu S, Adams D, Hayes J, Rowther F, Tolaymat I, Warr T, Snape TJ.. (2018) Towards identifying potent new hits for glioblastoma., 9 (11): [PMID:30568753] [10.1039/C8MD00436F] |